KLF10 and cholangiocarcinoma: Moreover, also according to TCGA-CHOL data, cholangiocarcinoma patients with lower KLF10 expression predicted poorer overall survival (Supplementary Figure 2B), disease-specific survival (Supplementary Figure 2C), and progression-free survival (Supplementary Figure 2D).